Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.94 NOK | -1.42% | +0.58% | +42.80% |
May. 30 | Transcript : Lytix Biopharma AS, Q1 2024 Earnings Call, May 30, 2024 | |
May. 30 | Lytix Biopharma AS Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+42.80% | 32.72M | |
+49.55% | 56.95B | |
+39.98% | 40.26B | |
-7.42% | 39.32B | |
-4.42% | 28.37B | |
+12.12% | 26.45B | |
-18.16% | 19.41B | |
+29.14% | 12.54B | |
+25.76% | 12.21B | |
-1.27% | 12.15B |
- Stock Market
- Equities
- LYTIX Stock
- News Lytix Biopharma
- Lytix Biopharma Secures NOK14.3 Million Research Grant for Skin Cancer Treatment